Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2

Clinical trial NCT04887948 · COMPLETED

Trial details

NCT number: NCT04887948
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumococcal Disease COVID-19 SARS-CoV-2 Infection

Start date: 2021-05-20
Primary completion: 2021-12-08
Enrollment: 570

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.